3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
36
Rectal Neoplasms
23
Stomach Neoplasms
19
Triple Negative Breast Neoplasms
16
Colorectal Neoplasms
14
Neoplasm Metastasis
12
Adenocarcinoma
9
Parkinson Disease 4, Autosomal Dominant Lewy Body
7
Pancreatic Neoplasms
7
Esophageal Neoplasms
7
Adenocarcinoma Of Esophagus
7
Nasopharyngeal Carcinoma
6
Colonic Neoplasms
6
Biliary Tract Neoplasms
6
Neoplasms
5
Carcinoma, Non-Small-Cell Lung
4
Esophageal Squamous Cell Carcinoma
3
Squamous Cell Carcinoma of Head and Neck
2
Spinocerebellar Degenerations
2
Pathologic Complete Response
2
Ovarian Neoplasms
2
Neoplasm, Residual
2
Locally Advanced Rectal Cancer
2
Cholangiocarcinoma
2
Carcinoma
2
Bile Duct Neoplasms
2
Anus Neoplasms
2
Advanced Solid Tumour
2
Somatostatinoma
1
Solid Tumors
1
Interventions
exemestane
2
Tamoxifen
2
Letrozole
2
Immunotherapy
2
Anastrozole
2
ribociclib
1
elacestrant
1
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
1
abemaciclib
1
Standard of Care
1
Radiosurgery
1
Practice Guidelines as Topic
1
Neoadjuvant Therapy
1
Methods
1
Leuprolide
1
Interviews as Topic
1
Goserelin
1
Genetic Testing
1
Genetic Counseling
1
Educational Status
1
Early Intervention, Educational
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Breast Neoplasms, Male
×
Capecitabine
×
90 days
×
Clear all
No trials found.